Noctrix Health developed and manufactures a novel non-invasive, wearable therapy to treat drug-refractory Restless Leg ...
As Philips reaches a consent decree agreement with the FDA that will temporarily suspend its sales of sleep therapy devices in the U.S., competitor ResMed, meanwhile, is ramping up its product ...
ResMed CEO Mick Farrell discusses the FDA-cleared artificial intelligence-enabled ‘Smart Comfort’ setting for AirSense 11 ...
Resmed said its Chief Financial Officer will retire in May and announced plans to acquire a startup with an FDA de novo ...
As competitor Philips continues to grapple with the effects of its long-standing recall of continuous positive airway pressure (CPAP) machines and other respiratory devices, ResMed is now issuing a ...
Resmed will buy Noctrix Health, the Pleasanton, Calif.-based developer of the Nidra Tonic Motor Activation therapy for ...
Connected sleep devicemaker ResMed today released the AirSense 11, its latest CPAP machine iteration, which includes a host of new features to treat obstructive sleep apnea. The new machine has many ...